Nouvelle déclaration d'incident
No de la demande: 2020-4266
Numéro de référence du titulaire d'homologation: 2020-US-019020
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G5L3
Incident chez un animal domestique
Pays: UNITED STATES
État: TEXAS
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2724-488
Nom du produit: Zodiac Spot On Flea Control For Cats and Kittens 2.5 lbs and Over
Liquide
Oui
Unités: mL
Site: Animal / Usage sur un animal domestique
Propriétaire de l'animal
Cat / Chat
Domestic Shorthair Cat
1
Homme
0.27
1.361
kg
Cutanée
Unknown / Inconnu
<=30 min / <=30 min
Système
Persisted until death
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 18-June-2020 the animal owner applied 1 tube of the product. Within 5 minutes the cat developed mydriasis and seizures. The cat developed decreased bowel movements and did not defecate after 18-June-2020. On 22-June-2020 the cat developed apparent blindness. The cat has been bathed by the animal owner twice daily since product application. The cat died the evening of 22-June-2020. Necropsy was not performed.
Mort
Assessment: (S)-Methoprene and the other ingredients in this product have a wide margin of safety. Risk of irritation including dermal, ocular (if ocular contact had occurred), and GI (if ingested). Ocular irritation could manifest as ocular discharge or redness. Loss of vision and mydriasis are not expected. Neurological signs such as those described in this report are also not expected. Necropsy may have provided further information but was not pursued by the animal owners. Other causes should be considered such as exposure to a permethrin containing canine flea and tick product, trauma, underlying neurological condition, infection, and parasites. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.